CNMD - Clearmind secures exclusive rights to potential PSTD therapies
2024-06-20 10:01:06 ET
More on CONMED
- CONMED Corporation 2024 Q1 - Results - Earnings Call Presentation
- CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript
- CONMED Non-GAAP EPS of $0.79 beats by $0.05, revenue of $312.3M beats by $5.58M
- CONMED Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on CONMED